Concord Biotech gets SEBI nod for IPO
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
The laboratory has the capacity to conduct 30,000+ tests in a month ranging from simple routine tests to semi-specialized and specialized tests
Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022
The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.
Subscribe To Our Newsletter & Stay Updated